Clinical Trials on CD123+ Acute Myeloid Leukemia in United States
Total 3144 results
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyActive, not recruitingAcute Myeloid LeukaemiaUnited States, Australia, France, Spain
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedAcute Myeloid LeukaemiaFrance, United States, Australia
-
Syndax PharmaceuticalsRecruitingAcute Myeloid LeukemiasUnited States
-
AstraZenecaTerminatedAcute Myeloid LeukaemiaUnited States, Australia
-
AstraZenecaCompletedAcute Myeloid LeukaemiaUnited Kingdom
-
GlaxoSmithKlineTerminatedLeukaemia, Myelocytic, AcuteUnited States, Australia, Canada
-
SanofiTerminatedAcute Myeloid LeukaemiaUnited States
-
Great Ormond Street Hospital for Children NHS Foundation...Wellcome TrustRecruitingRelapsed Acute Myeloid LeukaemiaUnited Kingdom
-
GlaxoSmithKlineCompletedLeukaemia, Myelocytic, AcuteUnited States
-
University of BirminghamAssistance Publique - Hôpitaux de Paris; Pfizer; Cancer Research UK; National Cancer...RecruitingAcute Myeloid LeukaemiaFrance, Switzerland, United Kingdom, New Zealand, Australia, Ireland
-
University of PennsylvaniaActive, not recruitingAcute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia, Refractory | Acute Myeloid Leukemia, PediatricUnited States
-
Terrence J Bradley, MDImago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New...RecruitingAcute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Acute Myeloid Leukemia, in RelapseUnited States
-
Bhavana BhatnagarCTI BioPharmaCompletedRecurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Untreated Adult Acute Myeloid Leukemia | Therapy-Related Acute Myeloid LeukemiaUnited States
-
Jacqueline Garcia, MDEli Lilly and CompanyCompletedCombination Merestinib and LY2874455 for Patients With Relapsed or Refractory Acute Myeloid LeukemiaRelapsed Adult Acute Myeloid Leukemia | Refractory Adult Acute Myeloid LeukemiaUnited States
-
University of NebraskaNational Cancer Institute (NCI)Active, not recruitingSecondary Acute Myeloid Leukemia | Therapy-Related Acute Myeloid Leukemia | Adult Acute Myeloid LeukemiaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia | Recurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingAcute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Untreated Adult Acute Myeloid Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Therapy-Related Acute Myeloid LeukemiaUnited States
-
Massachusetts General HospitalCelgene CorporationTerminatedAcute Myelogenous Leukemia | Acute Myeloid Leukemia (AML) | Acute Myelocytic Leukemia | Acute Granulocytic Leukemia | Acute Non-Lymphocytic LeukemiaUnited States
-
Washington University School of MedicineWithdrawnRefractory Acute Myeloid Leukemia | Relapsed Acute Myeloid LeukemiaUnited States
-
C. Babis AndreadisGateway for Cancer Research; AVEO Pharmaceuticals, Inc.TerminatedAcute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Relapsed Acute Myeloid LeukemiaUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedRecurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Untreated Adult Acute Myeloid LeukemiaUnited States
-
Massachusetts General HospitalExelixisCompletedRefractory Acute Myeloid Leukemia | Relapsed Acute Myeloid LeukemiaUnited States
-
SanofiTerminated
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedAcute Myeloid Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
GlaxoSmithKlineCompletedLeukaemia, Myelocytic, AcuteUnited States, France
-
Uma BorateRecruitingRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Acute Myeloid Leukemia With FLT3/ITD Mutation | Acute Myeloid Leukemia With KMT2A Rearrangement | Acute Myeloid Leukemia With NPM1 MutationUnited States
-
Uma BorateSumitomo Pharma Oncology, Inc.CompletedAcute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Therapy-Related Acute Myeloid LeukemiaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedChildhood Acute Megakaryocytic Leukemia (M7) | Childhood Acute Myeloid Leukemia/Other Myeloid MalignanciesUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Acute Myeloid Leukemia | Acute Myeloid Leukemia With FLT3/ITD Mutation | Refractory Acute LeukemiaUnited States
-
University of WashingtonTerminatedRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Myeloid NeoplasmUnited States
-
Yale UniversityPfizerTerminatedACUTE MYELOID LEUKEMIAUnited States
-
Weill Medical College of Cornell UniversityTerminatedAcute Myeloid Leukemia (AML)United States
-
Thomas Jefferson UniversityRecruitingRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedAdult Acute Myeloid Leukemia in Remission | Childhood Acute Myeloid Leukemia in RemissionUnited States
-
Dana-Farber Cancer InstituteNational Institute of Nursing Research (NINR)CompletedAcute Myeloid Leukemia (AML)United States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedRelapsed Acute Myeloid LeukemiaUnited States
-
Michael BoyiadzisMerck Sharp & Dohme LLCWithdrawnRefractory Acute Myeloid LeukemiaUnited States
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer InstituteActive, not recruitingRecurrent Adult Acute Myeloid Leukemia | Acute Myeloid Leukemia, in RelapseUnited States
-
Stanford UniversityCelgene CorporationCompletedAcute Myeloid Leukemia (AML) | Adult Acute Myeloblastic LeukemiaUnited States
-
Medical College of WisconsinRecruitingAcute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia RefractoryUnited States
-
Keystone Nano, IncMilton S. Hershey Medical Center; University of VirginiaNot yet recruitingAcute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia, RefractoryUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
St. Jude Children's Research HospitalSyndax PharmaceuticalsRecruitingRefractory Acute Myeloid Leukemia | Acute Leukemia of Ambiguous Lineage | Relapsed Acute Myeloid LeukemiaUnited States
-
University of PennsylvaniaRecruitingAcute Myeloid Leukemia (AML) | Multiple Myeloma (MM)United States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedChildhood Acute Myeloid Leukemia/Other Myeloid MalignanciesUnited States
-
University of Colorado, DenverKaryopharm Therapeutics IncRecruitingAcute Myeloid Leukemia | Acute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia RefractoryUnited States
-
Wake Forest University Health SciencesTerminated
-
University of Southern CaliforniaNational Cancer Institute (NCI)WithdrawnAdult Acute Myeloid Leukemia in Remission | Childhood Acute Myeloid Leukemia in RemissionUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingAcute Myeloid Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States